CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge

The COVID-19 pandemic presents an unprecedented challenge to global public health. Rapid development and deployment of safe and effective vaccines are imperative to control the pandemic. In the current study, we applied our adjuvanted stable prefusion SARS-CoV-2 spike (S-2P)-based vaccine, MVC-COV19...

Descripción completa

Detalles Bibliográficos
Autores principales: Lien, Chia-En, Lin, Yi-Jiun, Chen, Charles, Lian, Wei-Cheng, Kuo, Tsun-Yung, Campbell, John D., Traquina, Paula, Lin, Meei-Yun, Liu, Luke Tzu-Chi, Chuang, Ya-Shan, Ko, Hui-Ying, Liao, Chun-Che, Chen, Yen-Hui, Jan, Jia-Tsrong, Ma, Hsiu-Hua, Sun, Cheng-Pu, Lin, Yin-Shiou, Wu, Ping-Yi, Wang, Yu-Chiuan, Tao, Mi-Hua, Lin, Yi-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062487/
https://www.ncbi.nlm.nih.gov/pubmed/33888840
http://dx.doi.org/10.1038/s41598-021-88283-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062487/
https://www.ncbi.nlm.nih.gov/pubmed/33888840
http://dx.doi.org/10.1038/s41598-021-88283-8

Ejemplares similares